KOLINPHARMA S.p.A

KOLINPHARMA

IT | EN | FR | ES | DE

I prodotti Kolinpharma

News
News from the world KOLINPHARMA

25/10/2022 - published at 16.47

KOLINPHARMA^® signs an agreement with ASTAREAL^® AB for distribution in the Asian market

An important three-year agreement for distribution of products in Mainland China, Hong Kong, Macao and Taiwan

05/08/2021 - published at 16.06

Kolinpharma^® at VITAFOODS Europe 2021 in Geneva and at CPHI Worldwide 2021 in Milan

KOLINPHARMA^® strengthens its marketing and brand awareness strategy

26/08/2020 - published at 14.14

KOLINPHARMA^® expands its product portfolio with IVUXUR^® TABLETS.

KOLINPHARMA^® presents the new product IVUXUR^® TABLETS, which is added to the other 9 patented or patent pending products

16/04/2020 - published at 14.49

KOLINPHARMA^®:first patent for XINEPA^® in Israel and fifth outside Italy

Xinepa^® is a nutraceutical product already in possession of a double patent in Italy

10/03/2020 - published at 16.45

KOLINPHARMA^® obtains the patent in the U.S. of Dolatrox^®

It is the fourth patent that is added to Ivuxur^® and to the 2 of Xinepa^®

24/05/2019 - published at 10.54

KOLINPHARMA^® invests in product quality and safety

Strict product controls guarantee quality and safety for the consumer.

Media

Almetax Easy and tablets

Certified products

Company validations

Consumer Protection

Corporate compliance

Profile and organization

Research and development

Respect the environment

Xinepa Easy and tablets

Contact media relations

“Science accuracy and listen to people”

“Science accuracy and listen to people”